Abe M - Search Results

1

Glycemic control and survival in peritoneal dialysis patients with diabetes: A 2-year nationwide cohort study.

Abe M, Hamano T, Hoshino J, Wada A, Nakai S, Masakane I. Abe M, et al. Sci Rep. 2019 Mar 1;9(1):3320. doi: 10.1038/s41598-019-39933-5. Sci Rep. 2019. PMID: 30824808 Free PMC article. Clinical Trial.

2

Evaluation of the hemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: comparison between the hemodialysis and non-hemodialysis days.

Abe M, Kaizu K, Matsumoto K. Abe M, et al. Ther Apher Dial. 2007 Aug;11(4):288-95. doi: 10.1111/j.1744-9987.2007.00492.x. Ther Apher Dial. 2007. PMID: 17661835

3

Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis.

Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K. Abe M, et al. Expert Opin Pharmacother. 2010 Feb;11(2):169-76. doi: 10.1517/14656560903530683. Expert Opin Pharmacother. 2010. PMID: 20025554 Clinical Trial.

4

Relationship between erythropoietin responsiveness, insulin resistance, and malnutrition-inflammation-atherosclerosis (MIA) syndrome in hemodialysis patients with diabetes.

Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K, Soma M. Abe M, et al. Int J Artif Organs. 2011 Jan;34(1):16-25. doi: 10.5301/ijao.2011.6314. Int J Artif Organs. 2011. PMID: 21298620

5

The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.

Ito M, Abe M, Okada K, Sasaki H, Maruyama N, Tsuchida M, Higuchi T, Kikuchi F, Soma M. Ito M, et al. Among authors: abe m. Endocr J. 2011;58(11):979-87. doi: 10.1507/endocrj.ej11-0025. Epub 2011 Sep 15. Endocr J. 2011. PMID: 21921362 Free article. Clinical Trial.

6

The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.

Fujii Y, Abe M, Higuchi T, Mizuno M, Suzuki H, Matsumoto S, Ito M, Maruyama N, Okada K, Soma M. Fujii Y, et al. Among authors: abe m. Expert Opin Pharmacother. 2013 Feb;14(3):259-67. doi: 10.1517/14656566.2013.761690. Epub 2013 Jan 7. Expert Opin Pharmacother. 2013. PMID: 23289982 Clinical Trial.

7

Mineral metabolic abnormalities and mortality in dialysis patients.

Abe M, Okada K, Soma M. Abe M, et al. Nutrients. 2013 Mar 22;5(3):1002-23. doi: 10.3390/nu5031002. Nutrients. 2013. PMID: 23525083 Free PMC article. Review.

8

DPP-4 Inhibitors in Diabetic Patients with Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis in Clinical Practice.

Abe M, Okada K. Abe M, et al. Contrib Nephrol. 2015;185:98-115. doi: 10.1159/000380974. Epub 2015 May 19. Contrib Nephrol. 2015. PMID: 26023019 Review.

9

Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.

Kobayashi H, Abe M, Yoshida Y, Suzuki H, Maruyama N, Okada K. Kobayashi H, et al. Among authors: abe m. Int J Mol Sci. 2016 Apr 25;17(5):619. doi: 10.3390/ijms17050619. Int J Mol Sci. 2016. PMID: 27120597 Free PMC article.

10

Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis?

Abe M, Hamano T, Hoshino J, Wada A, Inaba M, Nakai S, Masakane I. Abe M, et al. Diabetes Res Clin Pract. 2017 Aug;130:211-220. doi: 10.1016/j.diabres.2017.06.012. Epub 2017 Jun 13. Diabetes Res Clin Pract. 2017. PMID: 28648854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,254 results

Search Page

Filters